Free Trial
NASDAQ:CGC

Canopy Growth (CGC) Stock Price, News & Analysis

Canopy Growth logo
$1.30 +0.11 (+8.82%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$1.29 0.00 (-0.39%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Canopy Growth Stock (NASDAQ:CGC)

Key Stats

Today's Range
$1.21
$1.34
50-Day Range
$1.13
$1.93
52-Week Range
$0.77
$8.65
Volume
9.85 million shs
Average Volume
6.32 million shs
Market Capitalization
$238.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Sell

Company Overview

Canopy Growth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

CGC MarketRank™: 

Canopy Growth scored higher than 56% of companies evaluated by MarketBeat, and ranked 1366th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Canopy Growth has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Canopy Growth has only been the subject of 1 research reports in the past 90 days.

  • Read more about Canopy Growth's stock forecast and price target.
  • Earnings Growth

    Earnings for Canopy Growth are expected to grow in the coming year, from ($2.81) to ($0.69) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Canopy Growth is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Canopy Growth is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Canopy Growth has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Canopy Growth's valuation and earnings.
  • Percentage of Shares Shorted

    9.85% of the float of Canopy Growth has been sold short.
  • Short Interest Ratio / Days to Cover

    Canopy Growth has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Canopy Growth has recently decreased by 0.57%, indicating that investor sentiment is improving.
  • Dividend Yield

    Canopy Growth does not currently pay a dividend.

  • Dividend Growth

    Canopy Growth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.85% of the float of Canopy Growth has been sold short.
  • Short Interest Ratio / Days to Cover

    Canopy Growth has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Canopy Growth has recently decreased by 0.57%, indicating that investor sentiment is improving.
  • News Sentiment

    Canopy Growth has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Canopy Growth this week, compared to 6 articles on an average week.
  • Search Interest

    4 people have searched for CGC on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Canopy Growth insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.30% of the stock of Canopy Growth is held by insiders.

  • Percentage Held by Institutions

    Only 3.33% of the stock of Canopy Growth is held by institutions.

  • Read more about Canopy Growth's insider trading history.
Receive CGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.

CGC Stock News Headlines

CGC - Canopy Growth Corp Financials - Morningstar
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Canopy Growth Corporation (CGC) - Yahoo Finance
CGC - Canopy Growth Corp Valuation - Morningstar
ATB Capital Markets Cuts Valuation on Canopy Growth Corp.
See More Headlines

CGC Stock Analysis - Frequently Asked Questions

Canopy Growth's stock was trading at $2.74 at the beginning of the year. Since then, CGC stock has decreased by 52.7% and is now trading at $1.2950.

Canopy Growth Corporation (NASDAQ:CGC) posted its quarterly earnings results on Friday, May, 30th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.66. The business had revenue of $45.30 million for the quarter, compared to analyst estimates of $71.84 million. Canopy Growth had a negative net margin of 195.76% and a negative trailing twelve-month return on equity of 88.54%.
Read the conference call transcript
.

Canopy Growth's stock reverse split before market open on Wednesday, December 20th 2023.The 1-10 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Canopy Growth investors own include NVIDIA (NVDA), Meta Platforms (META), Alibaba Group (BABA), Micron Technology (MU), GE Aerospace (GE), BMO Capital Markets () and Stifel Nicolaus ().

Company Calendar

Last Earnings
5/30/2025
Today
7/04/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CGC
Fax
N/A
Employees
3,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+54.4%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$429.86 million
Net Margins
-195.76%
Pretax Margin
-221.94%

Debt

Sales & Book Value

Annual Sales
$225.65 million
Price / Cash Flow
N/A
Book Value
$1.90 per share
Price / Book
0.68

Miscellaneous

Free Float
181,475,000
Market Cap
$238.11 million
Optionable
Optionable
Beta
0.73
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CGC) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners